LisaRobinDillerMD
Pediatric Hematology & Oncology • Boston, MACancer Genetics/Cancer Risk Assessment, Pediatric Solid Tumor Oncology
Dana-Farber Cancer Institute, Professor of Pediatrics, Harvard Medical School
Dr. Diller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
44 Binney Street
300 Longwood Avenue
Boston, MA 02115Phone+1 617-632-5642Fax+1 617-582-8218
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1988 - 1991- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1985 - 1988
University of California San Diego School of MedicineClass of 1985
Certifications & Licensure
MA State Medical License 1988 - 2025- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- Boston Magazine Castle Connolly, 2008-2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma Start of enrollment: 2003 Dec 01
- Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas Start of enrollment: 1996 Jan 01
- Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors Start of enrollment: 2001 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- Update on Surveillance for Wilms Tumor and Hepatoblastoma in Beckwith-Wiedemann Syndrome and Other Predisposition Syndromes.Jennifer M Kalish, Kerri D Becktell, Gaëlle Bougeard, Garrett M Brodeur, Lisa R Diller
Clinical Cancer Research. 2024-12-02 - Update on surveillance guidelines in emerging Wilms tumor predisposition syndromes.Jack J Brzezinski, Kerri D Becktell, Gaëlle Bougeard, Garrett M Brodeur, Lisa R Diller
Clinical Cancer Research. 2024-10-28 - Patterns of recurrence after radiotherapy for high-risk neuroblastoma: Implications for radiation dose and field.Kevin X Liu, Sherif G Shaaban, Jie Jane Chen, Rochelle Bagatell, Benjamin J Lerman
Radiotherapy and Oncology. 2024-09-01
Journal Articles
- Risk of Solid Subsequent Malignant Neoplasms After Childhood Hodgkin Lymphoma–Identification of High‐Risk Populations to Guide Surveillance: A Report from the Late Eff...David Tishler, Anna T Meadows, Joseph P Neglia, Kimberley Dilley, Rajaram Nagarajan, Laura T Martin, Lisa R Diller, Cancer
- Screening with Whole-Body Magnetic Resonance Imaging in Pediatric Subjects with Li–Fraumeni Syndrome: A Single Institution Pilot StudyJudy E Garber, Lisa Diller, Junne Kamihara, Allison F O'Neill, Pediatric Blood & Cancer
Press Mentions
- Preventing ‘Chemo-Brain’ with Antioxidants That Target the Spinal FluidSeptember 14th, 2022
- Preventing ‘Chemo Brain’ with Antioxidants Targeting the Spinal FluidSeptember 13th, 2022
Universal Newborn Genetic Screening for Pediatric Cancer Predisposition Syndromes: Model-Based InsightsMarch 25th, 2021- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
